![](https://isctr.org/wp-content/uploads/2019/10/ezgif.com-gif-maker-1.gif)
Translational Pathways for Cardiovascular Devices
Course Directors: Nabil Dib, MD; Spencer King, MD; Anthony DeMaria, MD
This course will fulfill an unmet educational need and provide you with valuable knowledge to be successful in developing therapies and expediting scientific discovery to patients. Ultimately, this course will enable you to contribute to product development to improve survival and the quality of life while decreasing costs. This course will change your approach to medicine and innovation. The information is critical for anyone who works in product development, whether as an innovator, physician, scientist, engineer, regulator, or at a reimbursement agency.
Preview These Free Lectures!
The TAVR Development from Concept to First in Man – Alain Cribier, MD, University of Rouen, France
The TAVR development from First in Man to Phase 3 and Beyond – Martin Leon, MD, Columbia University
Regulatory Requirement For Marketing Approval – Bram Zuckerman, MD, FDA
*For more information related to these Topics preview the Sampled Sessions below!
Microsoft PowerPoint
Course Content
Expand All
INTRODUCTION
Session Content
0% Complete
0/3 Steps
Session Content
0% Complete
0/8 Steps
SESSION I: BASIC KNOWLEDGE FOR CV DEVICES DEVELOPMENT
Session Content
0% Complete
0/1 Steps
Session Content
0% Complete
0/4 Steps
Session Content
0% Complete
0/7 Steps
Session Content
0% Complete
0/3 Steps
Session Content
0% Complete
0/19 Steps
Session Content
0% Complete
0/6 Steps
Session Content
0% Complete
0/3 Steps
Session Content
0% Complete
0/3 Steps
Session Content
0% Complete
0/7 Steps
Patients
3 Topics
|
1 Quiz
Expand
Panel Discussions
5 Topics
Expand
SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Panel Discussions
2 Topics
Expand
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Panel Discussions
3 Topics
Expand
Session Content
0% Complete
0/3 Steps
SESSION IV: TRANSLATIONAL PATHWAY FOR CORONARY STENT
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Panel Discussions
4 Topics
Expand
Session Content
0% Complete
0/4 Steps
SESSION V: TRANSLATIONAL PATHWAY FOR CATHETER ABLATION
Session Content
0% Complete
0/2 Steps
Panel Discussions
2 Topics
Expand
Session Content
0% Complete
0/2 Steps
SESSION VI: TRANSLATIONAL PATHWAY FOR VENTRICULAR ASSIST DEVICES
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Panel Discussions
2 Topics
Expand
Session Content
0% Complete
0/2 Steps
SESSION VII: TRANSLATIONAL PATHWAY FOR INTERVENTIONAL DEVICES FOR HEART FAILURE
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Panel Discussion
1 Topic
Expand
SESSION VIII: TRANSLATIONAL PATHWAY FOR LEFT ATRIAL APPENDAGE CLOSURE DEVICES
Session Content
0% Complete
0/2 Steps
Session Content
0% Complete
0/2 Steps
Panel Discussion
1 Topic
Expand